Journal articleJ Child Neurol · August 26, 2026
Diazepam nasal spray is approved to treat seizure clusters in patients aged ≥2 years. A long-term safety study in patients aged 6-65 years found a safety profile similar to diazepam rectal gel. We conducted an open-label, phase 1/2a trial of diazepam nasal ...
Full textLink to itemCite
Journal articleEpileptic Disord · August 2026
OBJECTIVE: To evaluate the safety, feasibility, and clinical outcomes of magnetic resonance-guided laser interstitial thermal therapy (LITT) in children under 2 years of age with medically refractory epilepsy. METHODS: We conducted a retrospective case ser ...
Full textLink to itemCite
Journal articleNat Commun · May 25, 2026
In drug-resistant temporal lobe epilepsy (DR-TLE), some seizures are clinically symptomatic while others remain electrographic despite arising from the same seizure-onset zone (SOZ), suggesting that clinical expression reflects network dynamics beyond seiz ...
Full textLink to itemCite
Journal articleJ Child Neurol · May 2026
Malan syndrome is an ultrarare overgrowth-intellectual disability syndrome caused by NFIX variants, characterized by intellectual disability, postnatal overgrowth, and dysmorphic features. Seizures in Malan syndrome remain poorly understood. We surveyed ca ...
Full textLink to itemCite
Journal articleJ Inherit Metab Dis · March 2026
Aromatic ʟ-amino acid decarboxylase (AADC) deficiency is a rare pediatric neurotransmitter disorder that typically necessitates lifelong care, and that carries a risk of childhood mortality. Eladocagene exuparvovec gene therapy is designed to restore AADC ...
Full textLink to itemCite
Journal articleEpilepsy Behav Rep · March 2026
In this analysis of dosing and titration in the CORE-VNS study, we aimed to replicate previously published findings related to dosing and titration of VNS Therapy and describe the impact of Scheduled Programming (SP).Participants who received their first V ...
Full textLink to itemCite
Journal articleEpilepsy Res · March 2026
RATIONALE: VNS is an efficacious therapy for people with epilepsy (PwE), but personalized implementation of VNS dosing and titration could be improved by measuring therapeutic engagement of cortical and subcortical physiology. METHODS: People with Drug-Res ...
Full textLink to itemCite
Journal articleLiaquat National Journal of Primary Care · January 1, 2026
Epilepsy, a neurological disorder characterized by recurrent seizures, affects millions globally, particularly in low-and middle-income countries like Pakistan. Despite its prevalence, stigma and misconceptions surrounding epilepsy persist, necessitating e ...
Full textCite
Journal articleNeurology · December 9, 2025
BACKGROUND AND OBJECTIVES: Dravet syndrome (DS) is an intractable developmental and epileptic encephalopathy caused primarily by pathogenic variants in the voltage-gated sodium channel α subunit 1 (SCN1A) gene. Patients with DS experience refractory seizur ...
Full textLink to itemCite
Journal articleEpilepsia · September 2025
OBJECTIVE: Benzodiazepine immediate-use seizure medications (ISMs; also called rescue therapies) are used to treat seizure clusters/acute repetitive seizures in patients with epilepsy. In the United States, diazepam nasal spray is an approved ISM for patie ...
Full textLink to itemCite
Journal articleEpilepsia Open · August 2025
OBJECTIVE: Microburst vagus nerve stimulation (μVNS) may reduce seizure frequency in drug-resistant epilepsy (DRE) via targeted thalamic plasticity. We prospectively investigated the role of thalamic resting-state functional connectivity (rsFC) in μVNS eff ...
Full textLink to itemCite
Journal articleEpileptic Disord · April 2025
OBJECTIVE: The aim of this paper was to visualize 3-dimensional (3-D) brain and electrode placement data for epilepsy surgery within an augmented reality (AR) environment using a wearable headset, with the ultimate goal of enhancing presurgical planning fo ...
Full textLink to itemCite
Journal articleCytometry B Clin Cytom · January 2025
The advent of high-dimensional imaging offers new opportunities to molecularly characterize diagnostic cells in disorders that have previously relied on histopathological definitions. One example case is found in tuberous sclerosis complex (TSC), a develop ...
Full textLink to itemCite
Journal articleEpilepsy Behav · February 2024
OBJECTIVE: The BUTTERFLY observational study aims to elucidate the natural trajectory of Dravet syndrome (DS) and associated comorbidities in order to establish a baseline for clinical therapies. We present the 12-month interim analysis of the study. MATER ...
Full textLink to itemCite
Journal articleJ Clin Neurophysiol · February 1, 2024
PURPOSE: The EEG is an essential neurological diagnostic tool. EEG abnormalities can guide diagnosis and management of epilepsy. There are also distinctive EEG waveforms that are seen in healthy individuals. It is critical not to misinterpret these as abno ...
Full textLink to itemCite
Journal articleBrain Stimul · 2024
BACKGROUND: Vagus nerve stimulation (VNS) at low frequencies (≤30 Hz) has been an established treatment for drug-resistant epilepsy (DRE) for over 25 years. OBJECTIVE: To examine the initial safety and efficacy performance of an investigational, high-frequ ...
Full textLink to itemCite
Journal articleEpileptic Disord · December 2023
OBJECTIVE: To describe the process of three-dimensional printing in epilepsy surgery using three different methods: low-force stereolithography (SLA), filament deposition modeling (FDM), and Polyjet Stratasys, while comparing them in terms of printing effi ...
Full textLink to itemCite
Journal articleEpilepsy Res · March 2023
INTRODUCTION: Protocadherin-19 (PCDH19)-clustering epilepsy is a distinct developmental and epileptic encephalopathy characterized by early-onset seizures that are often treatment refractory. Caused by a mutation of the PCDH19 gene on the X chromosome, thi ...
Full textLink to itemCite
Journal articleEpilepsy Behav · December 2022
PURPOSE: The purpose of this study is to evaluate adaptive functioning and neurodevelopment study assessments in a prospective study of patients with Dravet syndrome (DS). We present 3-month interim adaptive functioning and neurodevelopment data from the p ...
Full textLink to itemCite
Journal articleJ Clin Neurophysiol · September 1, 2022
PURPOSE: Stereotactic EEG (SEEG) is being increasingly used in the intracranial evaluation of refractory epilepsy in the United States. In this study, the authors describe current practice of SEEG among National Association of Epilepsy Centers tertiary ref ...
Full textLink to itemCite
Journal articlePhysiol Meas · July 18, 2022
Introduction. Epileptic seizures are common neurological disorders in the world, impacting 65 million people globally. Around 30% of patients with seizures suffer from refractory epilepsy, where seizures are not controlled by medications. The unpredictabil ...
Full textLink to itemCite
Journal articleEpilepsia Open · June 2022
OBJECTIVE: To assess retention, dosing, efficacy, and safety of perampanel in a large cohort of patients with epilepsy during routine clinical care. METHODS: PROVE was a retrospective, non-interventional Phase IV study (NCT03208660). Data were obtained ret ...
Full textLink to itemCite
Journal articleJ Clin Neurophysiol · September 1, 2021
PURPOSE: Triphasic waves (TWs) are defined as high-amplitude positive waveforms with preceding and after-going negative waves, typically seen in medically ill patients. TWs manifest in similar clinical presentations as other EEG encephalopathies; however, ...
Full textLink to itemCite
Journal articleGenet Med · May 2021
PURPOSE: Neurodevelopmental disorders (NDDs) encompass a spectrum of genetically heterogeneous disorders with features that commonly include developmental delay, intellectual disability, and autism spectrum disorders. We sought to delineate the molecular a ...
Full textLink to itemCite
Journal articleBMJ Neurol Open · 2021
INTRODUCTION: The Vagus Nerve Stimulation Therapy System (VNS Therapy) is an adjunctive neuromodulatory therapy that can be efficacious in reducing the frequency and severity of seizures in people with drug-resistant epilepsy (DRE). CORE-VNS aims to examin ...
Full textLink to itemCite
Journal articleAm J Hum Genet · September 5, 2019
Notch signaling is an established developmental pathway for brain morphogenesis. Given that Delta-like 1 (DLL1) is a ligand for the Notch receptor and that a few individuals with developmental delay, intellectual disability, and brain malformations have mi ...
Full textLink to itemCite
Journal articleNeurology · August 7, 2018
Congenital harlequin syndrome is rare dysautonomia of the face most often reported in adults and rarely in infants and children. It is a diagnosis of exclusion and a seemingly benign condition. We report a case of a 6-month-old girl with episodic unilatera ...
Full textLink to itemCite